Key Highlights
- LSE:KOO jumped 20.00% on 28 August 2026 to close at 195p.
- The shares opened at 162.50p, reached an intraday high of 203p and traded as low as 165p.
- Kooth's Market Capitalisation was around £70.8 million following the move.
- The stock had already gained 11.30% on 27 August, meaning the two-day move was particularly powerful.
- Trading Volume remained elevated, with approximately 678,941 shares changing hands on 28 August, following more than 1.1 million shares on 27 August.
- The latest rally follows strong operational progress reported in July, including expected H1 2026 adjusted EBITDA of £5.0 million to £5.4 million, compared with £1.6 million in H1 2025.
- Kooth reported H1 Revenue of approximately £30.8 million, with the temporary revenue decline largely reflecting planned tapering of California product-development revenue and foreign-exchange effects.
- Net cash increased to approximately £23.1 million at 30 June 2026, strengthening the balance sheet.
- The company's US expansion remains a major focus, particularly California, New Jersey and Michigan.
- Investors are increasingly assessing whether improving profitability and expanding US reach can support a sustained re-rating of LSE:KOO.
Kooth LSE:KOO Shares Surge 20% on 28 August 2026
Kooth plc was one of the most closely watched small-cap healthcare stocks on 28 August 2026, with LSE:KOO rising 20.00% to 195p.
The move was significant because it followed an 11.30% gain on 27 August, creating a powerful two-session rally. On 28 August, the shares opened at 162.50p, climbed as high as 203p and finished at 195p. The stock therefore came within striking distance of its latest 52-week high of 203p.
Trading activity was also substantial. Around 678,941 shares traded during the session, after approximately 1.17 million shares changed hands on the previous day.
The immediate question for investors is why the stock has suddenly attracted such strong buying interest.
The answer appears to be a combination of improving profitability, stronger cash generation, US expansion, confidence in Soluna and renewed expectations that Kooth can convert its growing digital mental-health platform into sustainable long-term Earnings growth.
Why Kooth Is Back in Focus
Kooth has developed into a specialist digital mental-health provider serving users across the UK and United States.
Its Investment proposition is becoming increasingly centred on the Soluna platform, which provides digital mental-health support to young people.
The company has spent several years building its US presence, particularly in California, and has expanded into additional states.
That strategy is now beginning to show more clearly in the financial numbers.
The company's H1 2026 update indicated that adjusted EBITDA is expected to reach £5.0 million to £5.4 million, compared with just £1.6 million in H1 2025.
That represents a dramatic improvement in profitability.
For investors, this may be more important than the headline revenue number.
Profit Growth Is Becoming the Central Story
Kooth's H1 revenue is expected to be approximately £30.8 million, compared with £32.1 million in H1 2025.
At first glance, declining revenue might appear disappointing.
However, the composition of that decline is important.
Kooth explained that the reduction reflected planned tapering of California product-development revenue and a £0.7 million adverse foreign-exchange impact, partly offset by revenue from the new Michigan contract.
At the same time, adjusted EBITDA increased dramatically.
That suggests the Business is becoming more efficient as certain investment-heavy activities taper and the underlying platform scales.
This is potentially a powerful combination.
If revenue stabilises while profitability continues improving, Kooth could generate significantly more cash from each pound of revenue.
California Remains the Most Important Market
California remains one of the most important components of the Kooth investment case.
The company's Soluna service has now entered its fourth year of the California contract and had reached approximately 187,000 registrations by the end of June 2026.
The company has also highlighted independent validation of Soluna's impact, including findings from Northwestern University's Lab for Scalable Mental Health.
For investors, the importance of California goes beyond current revenue.
A successful California deployment provides Kooth with a real-world reference case that can potentially support expansion into other US states.
That creates a potential network effect.
The more evidence Kooth accumulates around engagement, outcomes and cost-effective digital support, the easier it may become to demonstrate the value proposition to additional government and healthcare customers.
Michigan Is a Major Expansion Step
Michigan represents another important catalyst.
Kooth secured a $2.6 million first-year state contract covering digital mental-health services for up to 100,000 students aged 13 to 18. The programme was designed to address the challenges of providing support across a large geographic area that includes substantial rural communities.
This is strategically important because Michigan expands Kooth beyond its established California and New Jersey footprint.
The company is demonstrating that its digital-first model can be deployed across different geographic and demographic environments.
Investors will therefore be watching usage levels, engagement, contract performance and the possibility of future expansion.
The Michigan contract also contributed to H1 revenue in 2026, partially offsetting the planned decline in California product-development revenue.
New Jersey Provides Renewal Validation
Kooth's US strategy is not based entirely on winning new contracts.
Renewals are equally important.
The company successfully renewed its New Jersey contract, giving investors an important indication that its services can remain embedded within state-level mental-health infrastructure after an initial deployment.
This is crucial for the long-term investment case.
Winning a contract can create an initial revenue boost.
Renewing that contract demonstrates that the customer continues to see value.
A combination of new state wins and successful renewals could therefore create a stronger recurring-revenue platform.
The Soluna UK Opportunity
Another major catalyst is the expansion of Soluna into the UK.
Kooth has been preparing to launch the platform in the UK during 2026, building on technology and experience developed through its US operations.
This could potentially create an additional growth opportunity within Kooth's established home market.
The UK already provides Kooth with a strong institutional base.
Introducing an enhanced digital platform into this existing ecosystem could allow the company to cross-sell, improve service capabilities and potentially access additional funding channels.
For investors, this creates an important second growth avenue alongside the US.
Why the Balance Sheet Matters
Kooth entered the second half of 2026 with a strong financial position.
Unaudited net cash at 30 June 2026 was approximately £23.1 million, compared with £15.3 million at the same point in 2025.
This is particularly important for a small-cap growth company.
A strong cash position reduces immediate dependence on external financing and gives management greater flexibility to invest in product development, sales, technology and market expansion.
It also potentially reduces the risk of Shareholder dilution.
Kooth's 2025 year-end position already showed a debt-free balance sheet, and the improvement in net cash during H1 2026 strengthens the financial foundation further.
Why the 20% Rally Could Be More Than Momentum
The share-price reaction is notable because the company's operating story has changed materially over recent months.
At the start of 2026, investors were still dealing with the aftermath of lower 2025 revenue and EBITDA.
Kooth's 2025 revenue fell to £63.3 million from £66.7 million, while adjusted EBITDA declined to £11.3 million from £15.8 million. The company attributed much of the weakness to foreign-exchange effects, lower California product-development revenue and timing around the Michigan contract.
The H1 2026 numbers provide a different picture.
Revenue remains affected by the planned California transition, but profitability has improved sharply.
That could be causing investors to reassess the company's earnings trajectory.
The market may increasingly view the earlier revenue decline as a transition period rather than a deterioration in the underlying business.
Kooth's Addressable US Opportunity
One of the most compelling aspects of the long-term story is the potential size of the US market.
Kooth has previously estimated the addressable revenue opportunity from extending Soluna across the United States at more than $1 billion.
This should not be interpreted as guaranteed future revenue.
However, it illustrates the scale of the opportunity if the company can replicate its model across multiple states.
California provides the largest proof point.
New Jersey provides renewal validation.
Michigan demonstrates geographic expansion.
The next stage is determining whether this model can be repeated.
AI Could Become an Additional Growth Driver
Kooth has also been developing its technology and AI capabilities.
The company has previously highlighted an ethical AI strategy designed to enhance its products while maintaining safety and clinical standards.
For a digital mental-health provider, AI could potentially improve personalisation, user engagement, triage and accessibility.
However, this area requires careful execution.
Healthcare technology involving young people is subject to significant expectations around privacy, safety, clinical oversight and responsible deployment.
For investors, the opportunity is substantial, but credibility and governance will remain essential.
Why Investors Should Watch User Engagement
User registrations are becoming an increasingly important operating metric for Kooth.
The company reported 187,000 Soluna registrations in California by the end of June 2026, demonstrating substantial adoption.
But registrations alone are not enough.
Investors should also consider engagement, retention, utilisation and clinical outcomes.
A platform with millions of registrations but weak engagement would not necessarily produce sustainable commercial value.
Kooth's strategy is therefore increasingly dependent on demonstrating that digital mental-health support can produce measurable outcomes while remaining economically attractive to state and healthcare-system customers.
The Main Risk: Customer Concentration
One of the biggest risks investors should continue monitoring is customer concentration.
California is strategically important, and the scale of that relationship means changes in state funding, contract terms or policy priorities could have a material impact on Kooth.
The company has been reducing this risk by expanding into New Jersey, Michigan and the UK, but Diversification remains a work in progress.
The more states and customers Kooth adds, the less dependent the group should become on any individual contract.
Another Risk: Revenue Growth Versus Profit Growth
The latest figures show a dramatic improvement in EBITDA despite slightly lower revenue.
That is positive, but investors should watch whether this trend is sustainable.
Temporary benefits from lower investment spending or changes in revenue mix can improve margins.
Long-term shareholder value requires a combination of revenue growth, recurring contracts, sustainable margins and cash generation.
If Kooth can deliver all four, the current valuation could potentially look more attractive.
If profitability improves while revenue remains stagnant, the market may eventually question how much further Margin expansion can continue.
Why 203p Is an Important Level
Kooth reached an intraday high of 203p on 28 August, matching the recent 52-week high indicated in market data.
That makes the stock technically and psychologically important.
A sustained move above this area could reinforce the bullish momentum and potentially attract additional investors.
Conversely, failure to hold the gains could lead to profit-taking after the rapid two-day rise.
The fundamental milestones will ultimately matter more than technical levels, but the share price reaction shows that market sentiment has changed significantly.
What Could Drive LSE:KOO Higher From Here?
Several catalysts could continue supporting the shares.
Further US state contracts would strengthen the expansion narrative.
Successful Michigan implementation would demonstrate scalability.
Additional California evidence would reinforce Soluna's value proposition.
A successful UK Soluna rollout could open another growth channel.
Further improvement in EBITDA margins could increase confidence in the business model.
Strong cash generation could provide funding for expansion without substantial dilution.
Contract renewals would also be important because they demonstrate customer retention.
Together, these factors could support a sustained re-rating.
What Could Send LSE:KOO Lower?
The main downside risks include delays in new contract wins, customer concentration, slower US expansion, weaker-than-expected user engagement and pressure on government healthcare budgets.
Foreign-exchange movements can also affect reported results because Kooth has significant US exposure.
The company must also continue investing in technology and product development.
Finally, after a 20% one-day gain, expectations have risen sharply.
A stock can fall even when the underlying business remains healthy if investors believe the valuation has moved ahead of near-term earnings.
Investor Outlook for LSE:KOO
Kooth's 20.00% surge on 28 August 2026 has placed the company firmly back on the small-cap healthcare watchlist.
The rally followed another strong session and pushed the shares close to their 52-week high.
More importantly, the move coincides with a meaningful improvement in the company's operational profile.
H1 adjusted EBITDA is expected to reach £5.0 million to £5.4 million, more than three times the £1.6 million recorded in H1 2025, while net cash increased to approximately £23.1 million.
The US expansion story is also developing.
California remains the flagship market, Michigan adds another major state contract, New Jersey provides renewal evidence and the UK represents a potentially significant next phase for Soluna.
That combination gives Kooth multiple potential growth drivers.
However, investors should not ignore the risks.
The stock remains a small-cap healthcare technology investment with meaningful customer concentration, execution requirements and sensitivity to contract timing.
After the latest rally, the market will increasingly expect evidence that the company's improving profitability can be sustained while revenue growth resumes.
The most important indicators to watch are US contract wins, California retention, Michigan adoption, UK Soluna rollout, recurring revenue, EBITDA margins, cash generation and customer diversification.
If Kooth continues delivering across these areas, the 28 August rally could represent the start of a broader re-rating.
If growth disappoints or contract concentration becomes a problem, the sharp recent gains could also prove vulnerable to profit-taking.
For now, the central investment question is becoming increasingly clear:
Can Kooth turn its growing digital mental-health footprint into a consistently profitable, cash-generative international healthcare technology platform?
That is the question likely to determine whether LSE:KOO can sustain its latest momentum.






Please wait processing your request...